MediciNova, Inc.
NASDAQ:MNOVBiotechnology
Healthcare
$1.27 -1.32%
-$0.02 today
- Market cap
- $65.07M
- Beta
- 0.62
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$0.24
52W Low $1.17High $1.96
Volume 0.09M
Average 0.04M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$9.81M
FY 2025 · Annual
Investing Cash Flow
-$2,899.00
FY 2025 · Annual
Financing Cash Flow
$244,018.00
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (10.13M) | (14.07M) | (8.57M) | (11.05M) | (12M) |
| Depreciation & Amortization | 26.15K | 17.71K | 20.3K | 21.08K | 20.1K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.72M | 642.52K | 710.71K | 1.19M | 829.1K |
| Change in Working Capital | (1.21M) | 334.1K | 111.99K | (979.56K) | 1.17M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (1.03M) | 329.01K | 19.24K | (312.35K) | 459.87K |
| Other Working Capital | (181.42K) | 5.09K | 92.75K | (667.21K) | 705.15K |
| Other Non-Cash Items | 216.93K | 163.19K | 297.49K | 173.32K | 173.68K |
| Operating Cash Flow | (9.38M) | (12.91M) | (7.43M) | (10.64M) | (9.81M) |
| Capital Expenditures | (28.73K) | (5.01K) | (21.3K) | (895) | 0 |
| Acquisitions (Net) | 0 | 5.01M | 0 | 0 | 0 |
| Purchases of Investments | 0 | (59.88M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 19.88M | 39.93M | 0 | 0 |
| Other Investing Activities | 0 | (5.01M) | 0 | 198 | (2.9K) |
| Investing Cash Flow | (28.73K) | (40.01M) | 39.91M | (697) | (2.9K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 20.89M | 7.92K | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (112.26K) | 0 | 0 | 0 | 244.02K |
| Financing Cash Flow | 20.78M | 7.92K | 0 | 0 | 244.02K |
| Effect of Forex Changes | 26.55K | (16.81K) | 17.27K | 3.96K | 15.68K |
| Net Change in Cash | 11.39M | (52.93M) | 32.49M | (10.64M) | (9.55M) |
| Free Cash Flow | (9.41M) | (12.92M) | (7.45M) | (10.64M) | (9.81M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$12.0M
+ D&A$20.1K
+ Stock-Based Comp$829.1K
+ Deferred Tax$0
+ Working Capital$1.2M
+ Other Non-Cash$173.7K
= Operating Cash Flow-$9.8M
- Capex$0
= Free Cash Flow-$9.8M
Analysis
FY2025 free cash flow is -$9.8M. FCF conversion is 81.8% of net income. Operating cash flow was -$9.8M, with capex of $0. The largest bridge item is Working Capital at $1.2M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 12, 2026 | |
| SC 13G | SC 13G filing | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 29, 2026 | |
| SC 13D/A | SC 13D/A filing | Sep 29, 2026 | |
| 8-K | Current report | Sep 28, 2026 |
Does MNOV generate free cash flow?
MediciNova, Inc. (MNOV) generated -$9.81M of free cash flow in fiscal 2025.
How much operating cash flow does MNOV produce?
Operating cash flow was -$9.81M, before capital expenditures of $0.00.
Continue the stock analysis
Jump to another research area for this company.